Zhuang Li
Research Subjects
Zhuang Li has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Dengqun Sun
Department of General Surgery, The Chinese People’s Armed Police Forces Anhui Provincial Corps Hospital, Hefei, China
1 shared publication - Junfeng Gong
Department of General Surgery, The Armed Police Corps Hospital of Anhui, Hefei, China
1 shared publication - Lin Han
Department of General Surgery, The Armed Police Corps Hospital of Anhui, Hefei, China
1 shared publication - Yanjun Sun
Department of General Surgery, The Armed Police Corps Hospital of Anhui, Hefei, China
1 shared publication
Latest Publications
- 2 April 2024
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 136 (3) , 278-291
Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy
Gallbladder cancer is a common type of biliary tract tumor. Optimal management for early stage cases typically involves radical excision as the primary treatment modality. Various surgical techniques, including laparoscopic, robotic, and navigational surgery, have demonstrated favorable clinical outcomes in radical gallbladder excision. Unfortunately, most patients are ineligible for surgical intervention because of the advanced stage of the disease upon diagnosis. Consequently, non-surgical interventions, such as chemotherapy, radiotherapy, immunotherapy, and targeted therapy, have become the mainstay of treatment for patients in advanced stages. This review focuses on elucidating various surgical techniques as well as advancements in immunotherapy and targeted therapy in the context of recent advancements in gallbladder cancer research.
- 2 April 2024
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 136 (3) , 278-291
Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy
Gallbladder cancer is a common type of biliary tract tumor. Optimal management for early stage cases typically involves radical excision as the primary treatment modality. Various surgical techniques, including laparoscopic, robotic, and navigational surgery, have demonstrated favorable clinical outcomes in radical gallbladder excision. Unfortunately, most patients are ineligible for surgical intervention because of the advanced stage of the disease upon diagnosis. Consequently, non-surgical interventions, such as chemotherapy, radiotherapy, immunotherapy, and targeted therapy, have become the mainstay of treatment for patients in advanced stages. This review focuses on elucidating various surgical techniques as well as advancements in immunotherapy and targeted therapy in the context of recent advancements in gallbladder cancer research.